U.S. Residents Novartis Oncology
4 Rare Diseases Go to Novartis Oncology
     

Dermatofibrosarcoma Protuberans

Dermatofibrosarcoma protuberans (DFSP) is a rare, soft-tissue neoplasm of low- to intermediate malignancy. It constitutes less than 0.1% of all malignant neoplasms and less than 2% of all soft-tissue sarcomas.1,2 Although DFSP rarely metastasizes, it is highly invasive and locally aggressive.3

Epidemiology
DFSP is rare, with an estimated annual incidence of ~0.8 cases per million persons.1,3 It typically affects young to middle-aged adults (20-50 years old), and it occurs with almost equal frequency in men and women.1


References:
  1. Gloster HM, Jr. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35:355-374; quiz 375-376.
  2. Mendenhall WM, Zlotecki RA, Scarborough MT. Dermatofibrosarcoma protuberans. Cancer. 2004;101:2503-2508.
  3. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Dermatofibrosarcoma. Version 2. 2005. Available at: http://www.nccn.org/professionals/physician_gls/PDF/dfsp.pdf. Accessed April 23, 2006.
  Print This Page

Clinical trials

Rare Like Me

Disclaimer: This is an international website dedicated to rare diseases, and intended for healthcare professionals outside the US. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.
About Rare Diseases  |  DFSP  |  HES  |  Mast Cell Disease  |  Myelodysplastic / Myeloproliferative Diseases  |  Resources
Contact    |    Sitemap    |    Privacy
Use of this website is subject to our Terms of Use
©2009 Novartis AG